Konverge 40 mg/5 mg film-coated tablets
Film-coated tablet
Compare
|
PA0865/017/002
Authorised: 19/06/2009
Menarini International Operations Luxembourg S.A.
|
SPC
PIL
|
Konverge Plus 20 mg/5 mg/12.5 mg film-coated tablets
Film-coated tablet
Compare
|
PA0865/019/001
Authorised: 23/09/2011
Menarini International Operations Luxembourg S.A.
|
SPC
PIL
|
Konverge Plus 40mg/10mg/12.5mg film coated tablets
Film-coated tablet
Compare
|
PA0865/019/003
Authorised: 23/09/2011
Menarini International Operations Luxembourg S.A.
|
SPC
PIL
|
Konverge Plus 40mg/10mg/25mg film coated tablets
Film-coated tablet
Compare
|
PA0865/019/005
Authorised: 23/09/2011
Menarini International Operations Luxembourg S.A.
|
SPC
PIL
|
Konverge Plus 40mg/5mg/12.5mg film coated tablets
Film-coated tablet
Compare
|
PA0865/019/002
Authorised: 23/09/2011
Menarini International Operations Luxembourg S.A.
|
SPC
PIL
|
Konverge Plus 40mg/5mg/25mg film coated tablets
Film-coated tablet
Compare
|
PA0865/019/004
Authorised: 23/09/2011
Menarini International Operations Luxembourg S.A.
|
SPC
PIL
|
Kopen 250mg Tablets
Tablet
Compare
|
PA1418/014/003
Authorised: 24/07/1987
Athlone Pharmaceuticals Limited
|
SPC
PIL
|
Kopen Sugar Free 125mg/5ml Powder for Oral Solution
Powder for oral solution
Compare
|
PA1418/014/001
Authorised: 11/04/1988
Athlone Pharmaceuticals Limited
|
SPC
PIL
|
Kopen Sugar Free 250mg/5ml Powder for Oral Solution
Powder for oral solution
Compare
|
PA1418/014/002
Authorised: 11/04/1988
Athlone Pharmaceuticals Limited
|
SPC
PIL
|
Koselugo
Capsule, hard
Compare
|
EU/1/21/1552/001
Authorised: 17/06/2021
AstraZeneca AB
|
SPC
PIL
IPAR
|
Koselugo
Capsule, hard
Compare
|
EU/1/21/1552/002
Authorised: 17/06/2021
AstraZeneca AB
|
SPC
PIL
IPAR
|
Kovaltry
Powder and solvent for solution for injection
Compare
|
EU/1/15/1076/001-002
Authorised: 18/02/2016
Bayer AG
|
SPC
PIL
IPAR
|
Kovaltry
Powder and solvent for solution for injection
Compare
|
EU/1/15/1076/003-004
Authorised: 18/02/2016
Bayer Pharma AG
|
SPC
PIL
IPAR
|
Kovaltry
Powder and solvent for solution for injection
Compare
|
EU/1/15/1076/005-006
Authorised: 18/02/2016
Bayer Pharma AG
|
SPC
PIL
IPAR
|
Kovaltry
Powder and solvent for solution for injection
Compare
|
EU/1/15/1076/007-008
Authorised: 18/02/2016
Bayer Pharma AG
|
SPC
PIL
IPAR
|
Kovaltry
Powder and solvent for solution for injection
Compare
|
EU/1/15/1076/009-010
Authorised: 18/02/2016
Bayer Pharma AG
|
SPC
PIL
IPAR
|
KryptoScan, [81m Kr] Radionuclide generator
Radionuclide generator
Compare
|
PA0690/007/001
Authorised: 26/05/2006
Curium Netherlands B.V.
|
SPC
PIL
|
Kuvan
Powder for oral solution
Compare
|
EU/1/08/481/004
Authorised: 13/07/2017
BioMarin International Limited
|
SPC
PIL
IPAR
|
Kuvan
Powder for oral solution
Compare
|
EU/1/08/481/005
Authorised: 13/07/2017
BioMarin International Limited
|
SPC
PIL
IPAR
|
Kuvan
Soluble tablet
Compare
|
EU/1/08/481/1-3
Authorised: 02/12/2008
BioMarin International Limited
|
SPC
PIL
IPAR
|